ILDONG HOLDINGS CO.,LTD
000230 | KO
Overview
Corporate Details
- ISIN(s):
- KR7000230003
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 서초구 바우뫼로27길 2 일동제약빌딩, 서울특별시
- Website:
- https://www.ildongholdings.com
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-11 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 129.0 KB | ||
| 2025-09-11 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 44.3 KB | ||
| 2025-08-26 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 128.8 KB | ||
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 2.1 MB | ||
| 2025-07-30 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 16.3 KB | ||
| 2025-07-30 00:00 |
M&A Activity
[기재정정]타법인주식및출자증권처분결정
|
Korean | 21.5 KB | ||
| 2025-07-30 00:00 |
Related Party Transaction
타법인주식및출자증권처분결정
|
Korean | 15.8 KB | ||
| 2025-07-28 00:00 |
Report Publication Announcement
결산실적공시예고(안내공시)
|
Korean | 4.1 KB | ||
| 2025-07-08 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 136.0 KB | ||
| 2025-07-08 00:00 |
Major Shareholding Notification
최대주주등소유주식변동신고서
|
Korean | 50.2 KB | ||
| 2025-06-23 00:00 |
Related Party Transaction
타법인주식및출자증권처분결정
|
Korean | 17.1 KB | ||
| 2025-05-30 00:00 |
Governance Information
기업지배구조보고서공시
|
Korean | 1015.5 KB | ||
| 2025-05-27 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 128.8 KB | ||
| 2025-05-15 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.9 MB | ||
| 2025-05-12 00:00 |
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
|
Korean | 16.3 KB |
Automate Your Workflow. Get a real-time feed of all ILDONG HOLDINGS CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for ILDONG HOLDINGS CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ILDONG HOLDINGS CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea
293480
South Korea
293480
Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.
South Korea
128940
South Korea
128940
A holding company managing R&D-focused pharmaceutical, API, and medical device firms.
South Korea
008930
South Korea
008930
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden
HNSA
Sweden
HNSA
Develops innovative therapies for rare neurological diseases, focusing on conditions like narcolepsy.
United States of America
HRMY
United States of America
HRMY
Develops branded ophthalmic therapies and custom compounded solutions for North American eyecare.
United States of America
HROW
United States of America
HROW
Developing novel immunotherapies to treat aging-related chronic inflammation.
United States of America
HCWB
United States of America
HCWB
Develops cancer therapies using its proprietary ATAC Antibody-Drug Conjugate technology.
Germany
HPHA
Germany
HPHA
